Fluorocarbon aerosol medicaments

Details Fluorocarbon aerosol medicaments Fluorocarbon aerosol medicaments

A - Human Necessities

61

K

A61K 31/138 (2006.01) A61K 9/12 (2006.01) A61K 9/72 (2006.01) A61M 11/04 (2006.01) A61P 11/06 (2006.01) A61M 15/00 (2006.01)

Patent

CA 2586146

A pharmaceutical aerosol formulation for use for the administration of medicaments by inhalation consists essentially of particulate salmeterol xinafoate as medicament and 1,1,1,2-tetrafluoroethane as propellant, the formulation is free of surfactant, and the medicament is present in an amount of 0.01 to 1% w/w relative to the total weight of the formulation. There is also provided a process for preparing a filled pharmaceutical aerosol canister which comprises preparing a formulation of the invention and filling the formulation into a can which is closed with a metering valve. The formulation may be used for the manufacture of a medicament for administration by inhalation for the treatment of respiratory disorders such as asthma.

Affiliated with

Also associated with

Rating

Fluorocarbon aerosol medicaments does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Fluorocarbon aerosol medicaments, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fluorocarbon aerosol medicaments will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1463491